fda semaglutide update US approves weight loss drug Wegovy to prevent cardiovascular events BreezeMeds Reviewed: 2026 Consumer Report

Second, the study did not explore a stepwise increase in the concentrations of dulaglutide therapy administered to the animals

2.41% of people taking DPP-4 inhibitors developed epilepsy

According to the brand representative, GLP-1 has the same active ingredient as Ozempic & Wegovy (semaglutide) and GLP-1/GIP has the same active ingredients as Mounjaro & Zepbound (tirzepatide). The FDA recently announced that state-licensed pharmacies need to stop compounding GLP-1 medication

Don't take it late in the evening, as it may cause insomnia

It is also in development as an oral pill, which can be an alternative to semaglutide

Even more important to have that doctor advising and being along the ride with you